Skip to Main Content

Paper Details

PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation.
Nat Commun
21
2022
DMG, DMGs, Diffuse Midline Gliomas, MDM2, PPM1D, PPM1D phosphatase, gliomagenesis, high-grade gliomas, mouse, p53, pontine tumors, primary, whole genome sequences
Author NameAffiliation
Zachary J ReitmanDuke University
Zachary J ReitmanDuke University
Zachary J ReitmanDuke Cancer Institute, Duke University
Diana CarvalhoInstitute of Cancer Research
Travis I ZackDana Farber Cancer Institute
Kristine PeltonDana Farber Cancer Institute
Karsten KrugBroad Institute of MIT and Harvard
Federica PiccioniBroad Institute of MIT and Harvard
Rameen BeroukhimDana Farber Cancer Institute
Rameen BeroukhimBroad Institute of MIT and Harvard
David E RootBroad Institute of MIT and Harvard
David E RootBroad Institute of MIT and Harvard
Angel M CarcabosoHospital Sant Joan de Deu, Institut de Recerca Sant Joan de Deu
Benjamin L EbertBroad Institute of MIT and Harvard
Benjamin L EbertHoward Hughes Medical Institute
Benjamin L EbertDana-Farber Cancer Institute
Ozgun BaburCollege of Science and Mathematics, University of Massachusetts Boston
Mark W Kieran
Mark W Kieran
Mark W Kieran
Mark W Kieran
Chris JonesInstitute of Cancer Research
Hasmik KeshishianBroad Institute of MIT and Harvard
Keith L LigonDana Farber Cancer Institute
Steven A CarrBroad Institute of MIT and Harvard
Steven A CarrBroad Institute of MIT and Harvard
Timothy N PhoenixDivision of Pharmaceutical Sciences, University of Cincinnati
Timothy N PhoenixCincinnati Children's Hospital Medical Center
Pratiti BandopadhayayBroad Institute of MIT and Harvard
Pratiti Bandopadhayay
Pratiti BandopadhayayHarvard Medical School
  • 1 - 31

Datasets

Release 1.2